New Potent DprE1 Inhibitors for Tuberculosis Treatment
In a groundbreaking development in the fight against tuberculosis (TB), recent research has underscored the therapeutic potential of DprE1 (Decaprenylphosphoryl-β-D-ribofuranose 2′-epimerase) as a vital target...
















